Your browser doesn't support javascript.
loading
Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.
Doherty, Mark K; Korpanty, Grzegorz J; Tomasini, Pascale; Alizadeh, Moein; Jao, Kevin; Labbé, Catherine; Mascaux, Celine M; Martin, Petra; Kamel-Reid, Suzanne; Tsao, Ming-Sound; Pintilie, Melania; Liu, Geoffrey; Bradbury, Penelope A; Feld, Ronald; Leighl, Natasha B; Chung, Caroline; Shepherd, Frances A.
Affiliation
  • Doherty MK; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. Electronic address: mark.doherty@mail.utoronto.ca.
  • Korpanty GJ; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Tomasini P; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Alizadeh M; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada.
  • Jao K; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Labbé C; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Mascaux CM; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Martin P; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Kamel-Reid S; Laboratory Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada.
  • Tsao MS; Laboratory Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada.
  • Pintilie M; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada.
  • Liu G; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Bradbury PA; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Feld R; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Leighl NB; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Chung C; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada.
  • Shepherd FA; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
Radiother Oncol ; 123(2): 195-202, 2017 05.
Article in En | MEDLINE | ID: mdl-28363487
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Receptor Protein-Tyrosine Kinases / Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms / Mutation Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Radiother Oncol Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Receptor Protein-Tyrosine Kinases / Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms / Mutation Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Radiother Oncol Year: 2017 Type: Article